SCHEMBL19000689

SCHEMBL19000689

O=C(/C=C/c1ccc(O)cc1)NCCOCCOCCNC(=O)CN1CCN(C(=O)c2ccccc2-c2c3ccc(=O)cc-3oc3cc(O)ccc23)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FOLH1 Q04609 1/20 0.39
▸ ESR1 P03372 1/20 0.39
▸ HTR3A P46098 2/20 0.39
▸ AVPR2 P30518 1/20 0.39
▸ OXTR P30559 1/20 0.39
▸ PTGER3 P43115 2/20 0.39
▸ USP2 O75604 2/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ PLEC Q15149 1/20 0.39
▸ CA9 Q16790 5/20 0.38
▸ CA12 O43570 4/20 0.38
▸ CA1 P00915 4/20 0.38
▸ CA2 P00918 4/20 0.38
▸ GJA1 P17302 1/20 0.38
▸ GJB2 P29033 1/20 0.38
▸ ADRA1D P25100 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27005449 0.91 CA12 (0.39) ESR1HTR3AAVPR2OXTRPTGER3
SCHEMBL19000676 0.86 GBA1 (0.44) HTR3AMEN1KMT2ACA9CA12
SCHEMBL22007229 0.85 FOLH1 (0.43) FOLH1ESR1HTR3APTGER3USP2
SCHEMBL19000673 0.85 USP2 (0.42) FOLH1ESR1HTR3APTGER3USP2
SCHEMBL19000683 0.84 TGM2 (0.50) AVPR2OXTRUSP2MEN1POLB
SCHEMBL27057211 0.80 CA9 (0.45) FOLH1ESR1HTR3APTGER3USP2
SCHEMBL19000688 0.80 PDGFRB (0.33) —
SCHEMBL24855702 0.79 USP2 (0.54) USP2L3MBTL1MEN1POLBKMT2A
SCHEMBL22006192 0.78 CA12 (0.41) FOLH1ESR1HTR3APTGER3USP2
SCHEMBL19000672 0.78 CA12 (0.40) FOLH1ESR1HTR3APTGER3USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11466314-B2 Chromogenic peroxidase substrates AGILENT TECHNOLOGIES, INC. (US) 2022-10-11 — — US disclosed
US-20200157613-A1 CHROMOGENIC PEROXIDASE SUBSTRATES DAKO DENMARK APS (DK) 2020-05-21 — — US disclosed
US-20170175178-A1 CHROMOGENIC PEROXIDASE SUBSTRATES DAKO DENMARK APS (DK) 2017-06-22 — — US disclosed
US-20170175178-A1 CHROMOGENIC PEROXIDASE SUBSTRATES DAKO DENMARK APS (DK) 2017-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170175178-A1 CHROMOGENIC PEROXIDASE SUBSTRATES MPO, TPO, TYR FOLH1 376/4885ESR1 1091/4885HTR3A 1776/4885
US-11466314-B2 Chromogenic peroxidase substrates MPO, TPO, TYR FOLH1 314/4885ESR1 1189/4885HTR3A 1800/4885
US-20200157613-A1 CHROMOGENIC PEROXIDASE SUBSTRATES MPO, TPO, TYR FOLH1 314/4885ESR1 1189/4885HTR3A 1800/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback